3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Surgical Wound Infection
1
Pancreatic Neoplasms
1
Cystectomy
1
Interventions
Gemcitabine
3
Ethanol
3
fish oil triglycerides
2
S 1 (combination)
2
Metronidazole
2
Long-Term Synaptic Depression
2
Dexamethasone
2
pembrolizumab
1
pasireotide
1
nimotuzumab
1
ferumoxtran-10
1
alanylglutamine
1
Tobacco Use Cessation Devices
1
TachoSil
1
Sunitinib
1
Psychiatric Rehabilitation
1
Pregabalin
1
Polymerase Chain Reaction
1
Polygeline
1
Parenteral Nutrition
1
Pancrelipase
1
Oxaliplatin
1
Nutritional Status
1
Needles
1
Mirtazapine
1
Midazolam
1
Meperidine
1
Immunonutrition Diet
1
Hydrocortisone
1
Glucocorticoids
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Pancreatic Neoplasms
×
Cefuroxime
×
Clear all
NCT05784311
2024-10-21
SPARROW
Leiden University Medical Center
Phase 4
Recruiting
344 enrolled